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Abstract
Objectives: Abnormal cellular immune response has been considered to be responsible for oral lesions in recurrent 
aphthous stomatitis. Zinc has been known to be an essential nutrient metal that is necessary for a broad range of 
biological activities including antioxidant, immune mediator, and anti-inflammatory drugs in oral mucosal disea-
se. The objective of this study was to investigate the effects of zinc in a phorbol-12-myristate-13-acetate (PMA)-
treated inflammatory model on human gingival fibroblast cells (hGFs). 
Study Design: Cells were pre-treated with zinc chloride, followed by PMA in hGFs. The effects were assessed 
on cell viability, cyclooxygenease-1,2(COX-1/2) protein expression, PGE2 release, ROS production and cytokine 
release, 
Results: The effects were assessed on cell viability, COX1/2 protein expression, PGE2 release, ROS production, 
cytokine release. The results showed that, in the presence of PMA, zinc treatment leads to reduce the production 
of ROS, which results in decrease of COX-2 expression and PGE2 release. 
Conclusions: Thus, we suggest that zinc treatment leads to the mitigation of oral inflammation and may prove to 
be an alternative treatment for recurrent aphthous stomatitis. 
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Introduction
Recurrent aphthous stomatitis (RAS) is a common 
oral mucosal disorder characterized by recurrent pain-
ful oral aphthaes. The prevalence of RAS is between 
10%~20% in the general population (1,2). RAS is an 
inflammatory condition of unknown etiology. Various 
cytokines such as interleukin-6 (IL-6) and IL-8 have 
been implicated as potential etiopathogenic agents (3-5). 
RAS progression is regulated by the host response, and 
there is increasing evidence that non-immune cells 
such as human gingival fibroblasts (hGFs), participate 
in the host response (6). Other studies have reported 
that hGFs express Toll-like receptors and CD14, which 
is consistent with the finding that these cells respond 
to lipopolysaccharide (7). Arikan et al. demonstrated 
that lipid peroxidation seems to play a crucial role in 
the pathogenesis of recurrent aphthous stomatitis (8). 
RAU has known to evoke the Immune alterations by 
the activation of T lymphocytes and cytokines secretion 
(9). There have also been reported the dysfunction of 
enzyme superoxide dismutase (SOD), which participa-
tes in the inflammatory response of RAS (10). Recent 
studies reported that phorbol 12-myristate 13-acetate 
(PMA) could play an important role in the induction of 
cyclooxygenease-2(COX-2) expression and cytokines 
release (11-13). The synthesis of prostaglandin (PGs) 
in particular prostaglandin E2(PGE2) is regulated by 
main enzyme isoforms, cyclooxygenease-1(COX-1) and 
COX-2 (14). The PMA has known to induce the reacti-
ve oxygen species (ROS) mediated apoptosis in chronic 
inflammatory disease (15). It is well known that oxida-
tive stress can arise through the increased production 
of reactive oxygen species (ROS) and/or a deficiency of 
antioxidant defenses. Insufficient antioxidant enzyme 
synthesis may in turn be due to decreased micronutrient 
availability (8). Hence dietary intake of antioxidants is 
indispensable to protecting against oxidative-derived 
diseases. Increasing attention has been focused on the 
role of ROS produced by activated neutrophils during 
the inflammatory response (16). 
To improve the deficient antioxidant synthesis, sev-
eral clinical studies have suggested that zinc treatment 
could be useful to balance the redox potential (17,18). 
Zinc, thus not only function as an antioxidant but is also 
an anti-inflammatory agent. Zinc ions regulated T- and 
B-lymphocyte function, making it vital for the main-
tenance of normal immune function and resistance to 
infection (19,20). Zinc supplementation has been shown 
to have a favorable effect on fibrosis (21,22), metabo-
lism in the thyroid gland (23), anti-oxidation(18), and 
anti-depression (24). Zinc is an essential nutrient that is 
necessary for a broad range of biological activities. To 
date, more than 300 zinc-containing enzymes have been 
identified. Zinc deficiency causes biological dysfunction 
of gene expression, protein synthesis, immunity, skele-
tal growth and maturation, gonadal development, preg-
nancy, taste perception, and appetite (9,25-29). Some 
researchers have investigated the possible correlation 
of some oxidative stress parameters in Behcet’s disease 
and reported that zinc levels were inversely correlated 
with the clinical manifestation index (30,31), which 
demonstrated the importance of zinc as an antioxidant 
in inflammation-induced cells. Increasing evidence de-
monstrates that zinc has an anti-inflammatory effect 
(32). An earlier report showed that injection with zinc 
sulfate reduced LPS-induced teratogenicity in mice (19) 
and a recent study found that injection with zinc sulfate 
alleviated LPS-induced neurodevelopmental damage in 
the fetal brain (33). Although previous studies have re-
ported that zinc can reduce inflammation, it is unclear 
which cytokines are involved and reduced by zinc in the 
inflammatory state. 
The purpose of the present study was to investigate the 
effect of zinc on the process of wound healing in hu-
man gingival fibroblasts cells on an in vitro Phorbol-
12-myristate-13-acetate (PMA)-induced inflammatory 
model. Also, the activation profiles of inflammatory 
cytokines were revealed in response to zinc treatment. 
Material and Methods 
- Chemicals and Reagents
Phorbol-12-myristate-13-acetate (PMA), Zinc chlori-
de (ZnCl2), 3-(4,5-dimethylthiazolyl-2)-2,5-diphen-
yltetrazolium bromide (MTT), dimethyl sulfoxide 
(DMSO) and 2’, 7’-dichlorodihydrofluorescein diacetate 
(H2DCF-DA), Trisma base, sodium azide, sodium chlo-
ride and phenylmethylsulphonyl fluoride were purcha-
sed from Sigma (St. Louis, Mo, USA). Protein inhibitor 
cocktail were purchased from roche (roche, Mannheim, 
Germany).
- Primary Cell Culture 
Human gingival fibroblast cells (hGFs) were obtained 
from three healthy adults visiting the Chonnam Natio-
nal University Hospital for a gingivectomy. The gingi-
val tissues were finely cut with scissors and cultured in 
an alpha minimum essential medium (α-MEM) (Gib-
coBRL, Rockville, MD, USA) supplemented with 10% 
heat-inactivated fetal bovine serum and 1% antibiotic–
antimycotic solution (Cambrex Bio Science, Baltimore, 
MD, USA) at 37 °C in a 5% CO2 humidified chamber. 
The medium was replaced with fresh medium and the 
adherent hGFs were allowed to reach approximately 
70% confluence. The cells were then detached using 
trypsine-ethylenediamine tetra acetic acid (trypsin-re 
TA: GibcoBRL, Rockville, MD, USA) solution and pla-
ted again (subcultured) in 6-well plates for each expe-
riment. 
- Cell viability assay
The cell viability was evaluated using the (3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
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(MTT; Sigma–Aldrich) assay. The cells were seeded at 
5 x 103 cells per 200 uL of medium in 96-well plates, 
and cultured for 1 day at 37 °. Various concentrations 
(0,1,5,10,20, and 50 uM) of ZnCl2 for a zinc donor were 
added in each well with phorbol 12-myristate 13-acetate 
(PMA, 1uM), and the cells were subsequently incubated 
at 37° for 24 hours. After removing the medium, 100 
uL of MTT (50 ug/ml) was added to the cells. The cells 
were incubated at 37° for 4 hours and 30 minutes to al-
low color development, and the formazan product was 
solubilized by the addition of 50 ml dimethyl sulfox-
ide (Calbiochem Bio-Mol, La Jolla, CA). Optical den-
sity was measured at 570 nm and reference with 655nm 
using a microplate reader (Bio-Rad, Hercules, CA).
- Western blotting
The hGFs were seeded at 5 x 104 cells per well in ά-MEM 
media, and cultured for 1 day. The ZnCl2 (1,5,10 and 20 
uM) was then added to each well in the presence of PMA 
(1uM), and the cells were incubated for 24 hours. The 
medium was removed and washed twice with PBS. Cell 
lysates were then prepared in 200 ul of cold lysis buffer 
(1% NP-40,50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 
0.02% sodium azide, 150 mg/ml phenylmethylsulpho-
nyl fluoride, protein inhibitor cocktail). Thirty milli-
grams of cell lysates were separated in a 10% sodium 
dodecyl sulfate polyacrylamide gel and transferred onto 
a polyvinylidene difluoride membrane (Amersham, Ar-
lington Heights, IL). The membrane was blocked with 
blocking solution [5% skim milk in Tris-Buffered Saline 
and Tween 20(TBST) (2.42 g/L Tris–HCl, 8 g/L NaCl, 
0.1% Tween 20, pH 7.6)] for 30 minutes and rinsed brie-
fly in TBST. The membrane was incubated overnight 
at 4° with anti-COX-1 (1:1000; Santa Cruz Biotechno-
logies, Santa Cruz, CA), anti-COX-2 (1:1,000; Abcam, 
Cambridge, UK), and Glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) antibody (1:2,500; Santa Cruz). 
After rinsing with TBST, the membrane was incubated 
for 1 hour with anti-rabbit and anti-mouse horse radish 
peroxidase-conjugated (1:2,000) secondary antibody. 
Finally, the membrane was washed in TBST, and the 
immunoreactivities of the proteins were detected using 
an enhanced chemiluminescence detection kit (Amers-
ham) and the levels were determined by densitometric 
analysis using Scion Image software (Scion Corp, Fre-
derick, MD). 
- Enzyme-Linked Immunoassay for PGE2
The PGE2 expression level, the main metabolite of COX, 
was used in all subsequent experiments for this study. 
The amount of PGE2 was measured in the supernatants 
using a commercially available enzyme immunoassay 
kit (R&D System, Minneapolis, MN, USA) according 
to the manufacturer’s instruction. The hGFs were see-
ded at 5 x 104 cells per well in ά-MEM media, and cul-
tured for 1 day. The ZnCl2 (1, 5, 10 and 20 uM) was then 
treated to each well in the presence of PMA (1uM), and 
the cells were incubated for 24 hours. After 24 hr incu-
bation, the absorbance for PGE2 was measured at 586 
nm by using a colorimetric microplate reader (Bio-rad, 
Hercules, CA, USA). 
- Detection of total ROS formation with flow cytome-
try 
Total reactive oxygen species (ROS) were assayed using 
2’, 7’-dichlorodihydrofluorescein diacetate (H2DCF-
DA). DCF-DA enters cells passively, where it is enzy-
matically deacetylated by esterases to the non-fluores-
cent 2, 7- dihydrodichlorofluorescein (DCF-H). In the 
presence of oxidizing molecules such as O2-, DCF-H is 
converted to the highly fluorescent DCF. To measure 
intracellular ROS levels, the hGFs were seeded at 5 x 
104 cells per well in media, and cultured for 1 day. The 
ZnCl2 (1,5,10 and 20 uM) was then treated to each well 
in the presence of PMA (1uM), and the cells were in-
cubated for 24 hours. After incubation, the cells were 
washed with PBS containing 10 nM glucose and trea-
ted with 10 mM H2DCF-DA for 20 minutes. The cells 
were detached using trypsin-EDTA solution, and ROS 
levels were analyzed using flow cytometry (Beckman 
Coulter Fullerton, CA) at 485 nm excitation and with 
530 nm emission filters. To monitor the ROS formation, 
cells grown on cover slips were incubated with 10 nM 
of DCF-DA for 20 minutes. After the cells were washed 
with PBS containing 10 mM glucose, DCF fluorescence 
intensity was monitored using a confocal microscope 
(Carl Zeiss, Oberkochen, Germany) set at excitation and 
emission wavelengths of 488 and 525 nm, respectively.
- Cytokine profiling
To assess cytokine production profiles, the supernatant 
from the cultured hGFs was collected and assayed using 
a human inflammation antibody array (R&D Systems, 
Minneapolis, MN, U.S.A.) according to the instruction 
manual. This method uses a membrane coated with 
specific antibodies for each cytokine forming an array. 
The cytokine signal was detected using an ECL detec-
tion kit (Promega, Medison, WI, USA) and quantified 
by densitometric analysis using Scion Image software 
(Scion Corp, Frederick, MD, USA). The signal intensity 
of each spot was adjusted to the corresponding internal 
control provided for each membrane by the manufac-
turer (cytokine profiling). The ratio of expression was 
calculated by dividing the signal intensity of each cyto-
kine by the signal intensity of the internal control for 
each sample.
- Statistics
Data is expressed as the mean ± standard deviation. All 
experiments were carried out three times. The differen-
ces between the groups were evaluated using one way 
ANOVA. Data were considered statistically significant, 
at P < 0.05.
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Results 
- The cell survival effects of zinc in PMA-treated hGFs
To determine the effects of Zinc on cell survival in 
PMA-treated hGFs, cells were treated by 1μM of PMA 
with or without Zinc in a dose dependent manner. In the 
PMA-treated hGFs, cell survival was decreased to 80% 
as shown in fig. 1a. However, zinc could recover the cell 
survival to around 100% of control. 
- The effects of zinc on COX protein expression and 
PGE2 release in PMA-treated hGFs
The effect of zinc was investigated on COX protein 
expression in PMA-induced hGFs using western blot 
analysis. Protein expression of COX-2 after PMA 
treatments was revealed in the hGFs (Fig. 1b). After the 
zinc treatment, COX-2 expression was significantly de-
creased to against PMA induced inflammatory respon-
se (Fig. 1b). However, PMA induced decrease of COX-1 
expression, while ZnCl2 supplementation recovered to 
control levels (Fig. 1b). The release of PGE2 was increa-
sed to 1850 pg/mL in PMA-treated hGFs (Fig. 1c). On 
the other hand, PGE2 release was reduced to 1600 pg/
mL in the presence of zinc (20 μM). 
- The effects of zinc on ROS levels in PMA-treated hGFs
To assess the effects of zinc on intracellular ROS le-
vels in the PMA-treated hGFs, the production of in-
tercellular ROS levels were measured using DCF-DA 
fluorescence. As shown in fig. 2a, DCF-DA fluorescen-
ce was increased by PMA to 83.7% in hGFs. However, 
zinc (20μM) on PMA-treated cells decreased the DCF-
DA fluorescence to 67.5%. To confirm this result, we 
compared to between PAM treatments only and ZnCl2 
supplemented groups by confocal microscopy (Fig. 2b). 
Significant DCF fluorescence was seen in the PMA-
treated hGFs, but Zinc supplemented groups did not 
have DCF fluourescence in the zinc (10μM & 20μM) 
treated with PMA. 
- The effects of zinc on cytokine production in PMA-
treated hGFs 
To assess cytokine production, supernatants for hGFs 
cultured with zinc in the presence of PMA were collec-
ted after 24 hr. Cytokine profiles were assessed using 
a cytokine antibody array that can detect 40 different 
basal levels of a number of cytokines (Fig. 3.a). In the 
results, four innate cytokines, four chemokines, and one 
not-distinguished (N.D.) cytokine were represented.
Among these cytokines, growth-regulated oncogene-
Fig. 1. Effects of zinc on PMA-treated cell survival, COX-1/2 protein expressions and PGE2 release in hGFs. (a) The cell viability was 
assessed using an MTT assay for the indicated concentrations of ZnCl2 (0, 1, 5, 10, 20, and 50 µM) in the presence of PMA (1 µM). Data 
are reported as the mean ± SD (n = 3). (b) The cyclooxygenase -1/2 (COX-1/2) expressions and COX-2 expression level in hGFs were 
represented. The cells in each group were prepared for immunodetection with anticyclooxygenase-1 or 2 antibodies. The membranes 
were denuded and GAPDH was employed to load the same protein concentration. Densitometric analysis of COX-2 represents the mean 
ratio ± SD from three separate experiments. Significant differences are indicated as *p < 0.05 compared to PMA. (c) Released PGE2 was 
measured from recuperation of the culture medium from the previously mentioned condition, and these were processed for analysis by 
ELISA.
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alpha (GROα), interleukin-6 (IL-6), macrophage migra-
tion inhibitory factor (MIF), and stromal cell-derived 
factor-1(SDF-1) of innate cytokines were measured in 
the media (Fig. 3b). GROα and SDF1 levels were increa-
se by PMA, however, zinc supplements decrease to con-
trol levels or lower of control. IL-6 showed the greatest 
amount of release in response to PMA, increasing sig-
nificantly to 2.4-fold of the control level. However, zinc 
(20 μM) led to a decrease in IL-6 release; reducing the 
level to 0.5-fold of the control.  MIF levels were decrea-
sed by PMA. In zinc supplements with PMA, MIF le-
vels were decrease more comparing to PMA treatments 
only.
Of the chemokine, interleukin-8 (IL-8), regulated on 
activated normal T-cell expressed and secreted (RAN-
TES), monocyte chemoattractant protein-1 (MCP-1), 
and serpin E1 were assayed (Fig. 3c). IL-8, an impor-
tant mediator of the innate immune response, was in-
creased significantly to 2.7-fold the level of controls in 
PMA treated hGFs. In the PMA + zinc (20uM) group, 
IL-8 was significantly decreased to the half level of con-
trols. MCP-1 and Serpine E1 were diminished to about 
0.2-fold of the unchallenged controls after zinc (20 uM) 
treatment in the presence of PMA. PMA induced RAN-
TES levels to 1.5-fold of control. At 20uM, zinc attenua-
ted RANTES levels which were induced by PMA. 
In N.D., sCIAM-1 was significantly increased to 15-
fold the level of control in PMA-treated-hGFs (Fig. 3d). 
However, zinc led to a decrease in sICAM-1 release, re-
ducing the levels to those of the control cells.
Discussion
Although principle etiology of oral inflammatory di-
sease such as RAS is unclear, some researchers have 
proposed aphthous formation as a cause due to oxidati-
ve stress. (8,34). Recurrent aphthous stomatitis (RAS) 
is characterized by the appearance of initially necrotic 
ulcers (9). Immune alterations have been observed re-
sulting in the activation of T lymphocytes, cytokines 
secretion (9). Changes have also been reported in ele-
ments of the salivary defense system, such as the en-
zyme superoxide dismutase (SOD), which participates 
in the inflammatory response of RAS (10). In inflam-
matory model, PMA has the function of cell death and 
inflammatory response by cytokines regulation such as 
IL-6, IL-8 and T-cell activation including our results 
(12,35) . We suggested that PMA initiated inflamma-
tory response to contribute to its pathogenesis. 
Zinc therapy has been used extensively in clinical den-
tistry. Moreover, zinc is an important component of 
restorative materials and is also used as an active com-
ponent in toothpaste and mouth-rinses. Clinical stud-
ies have shown that zinc is  several beneficial effects 
such as antioxidant and anti-inflammatory properties in 
Fig. 2. Effect of zinc on PMA - treated ROS generation in hGFs. (a) The DCF fluorescence distribution is represented by flow cytometry histo-
grams (X axis: log of the fluorescence intensity; Y-axis: cell number). (b) Green fluorescence of DCF-DA, indicating intracellular ROS forma-
tion, was detected by confocal microscopy. All magnifications are × 200.
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psoriasis, hair loss, wound healing, leg ulcers (36-38). 
Moreover, zinc is an essential element and a well-esta-
blished antioxidant and zinc deficiency has been repor-
ted to be a potential risk factor for oral disease (39), (40). 
Chen and Liao et al. suggest that zinc can have either 
positive or negative effects on the physiology of cells 
depending on the local concentration, localization, and/
or state (40,41). In this study, zinc ions supplementation 
could be apply oral disease by inflammatory response 
such as aphthous ulcer, aphthous stomatitis.
In the present study, hGFs were treated with PMA to 
induce inflammation for an in-vitro experiment model. 
A inducible COX-2 expression in quiescent fibroblasts 
in response to stimulation with PMA is known to sig-
nal via protein kinase C (PKC) and its downstream 
signaling molecule, mitogen activated kinase (MAPK) 
(42,43). The treatment of PMA (1uM) subsequently led 
to the ROS generation, COX-2 expression, PGE2 relea-
se, and cell viability decrease. The ability of zinc to 
reduce inflammation is known that zinc could lead the 
intracellular ROS scavenging and relive cellular oxida-
tive stress. In present study, zinc treatment was shown 
to scavenge intracellular ROS, which mediate COX-2 
expression, and inhibit the release of PGE2. COX pro-
tein played different roles according to the cause of 
inflammatory cause of inflammatory response. COX-2 
appears to be the dominant source of prostaglandin for-
mation in inflammation. Increase of COX-2 expressed 
on provocation of inflammatory cells. COX-2 regulation 
usually treated to chronic inflammatory diseases (44). 
COX-1 is constitutively expressed in resident inflamma-
tory cells, and there is evidence for induction of COX-1 
during LPS-mediated inflammatory response and cellu-
lar differentiation (44). However, the function of COX 
protein is not understood yet. 
Given the antioxidant capacity of zinc on oxidative 
stress, zinc might protect cells indirectly against ROS 
and subsequently relieve the anti-inflammatory reaction 
involving the COX-2 and PGE2 pathway. Other reports 
confirm that serum zinc levels in patients with RAS 
were significantly lower than in controls (45). Low zinc 
levels in our patients may be probably due to the increa-
sed consumption of zinc: (1) the continuous process of 
ulcer healing; (2) because of the antioxidant activity of 
zinc as it may act as free radical scavenger; (3) existen-
ce of completion in intestinal absorption; and the inverse 
Fig. 3. Effect of zinc on PMA - treated cytokines release in hGFs. (a) Expression of cytokine release in the presence or absence of zinc on PMA-
induced hGFs. (PC, Positive Control; 1, GRO-alpha; 2, sICAM-1; 3, IL-6; 4, IL-8; 5, RANTES; 6, SDF-1; 7, MCP-1; 8, MIF, 9, SerpinE1). (b) 
Innate cytokines, (c) chemokines, and (d) not-distinguished cytokines were represented. For investigation of released cytokines, supernatants 
was harvested after 24 hr and then assayed using a cytokine profile array kit. Bars represent the mean ratio ± SD from the 2 experiments. 
Significant differences are indicated as *p < 0.05 compared to PMA. 
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relationship between copper and zinc concentration (46). 
We suggested that aphthous ulcers were chronic infla-
mmatory disease by COX-2 and PGE2. Moreover, Zinc 
supplementation might apply treatments of inflammatory 
response by ROS scavenge in zinc deficiency patients.
Cytokines and chemokines are known to play a pivotal 
role in the immunopathology of a number of immune 
diseases, and release of appropriate cytokine is essential 
for the initiation and effector stages of immunity and 
inflammation (47). The level of inflammatory cytokines 
could reflect process and development of oral disease in 
patient (48). Zinc treatment significantly decreased IL-6 
and IL-8 release in PMA-treated hGFs. Their function 
is mediated by primary cytokines such as IL-1beta and 
TNF-alpha, which is secreted within minutes in res-
ponse to stimuli (49). These kinds of cytokines lead to 
increased vascular permeability to IL-6 and recruit the 
leukocytes to the region, including those expressing 
IL-8 (50). The fact that IL-6 and IL-8 were increased 
in PMA-treated hGFs indicates that primary cytokines 
were effective in immediately enhancing the inflam-
matory response, so that the IL-6 and IL-8 levels are 
elevated in an autocrine manner. On the other hand, the 
IL-6 and IL -8 levels were decreased by zinc, resulting 
from autocrine suppression of the inflammatory respon-
se. IL-6 and IL-8 
In this study, MCP-1 and Serpine E1 were significantly 
decreased by zinc treatment in the presence of PMA. 
Also, RANTES release was recovered from a higher le-
vel in PMA-treated hGFs. RANTES, MCP-1, and Serpin 
E1 are chemokines produced in response to stimulation 
by cytokines such as IL-6 and TNF-α, and are secreted 
by a variety of cells, including vascular smooth muscle 
cells (VSMCs), epithelial cells, T cells, macrophages, 
and platelets (51,52). RANTES and MCP- 1 belong to a 
chemotactic cytokine family and are responsible for the 
chemotactic migration and activation of neutrophils and 
other cell types (such as monocytes, lymphocytes, ba-
sophils, and eosinophils) at sites of inflammation. The 
decrease of  RANTES, MCP-1, and Serpine E1 by zinc 
treatment in presence of PMA is thus reasonable to sug-
gest that zinc probably contribute to relieve the recruit-
ment of inflammatory cells in the periodontal tissue. 
Previously, it has been reported that gingival fibroblasts 
produce the alpha chemokine, IL-8, upon stimulation 
by lipopolysaccharide or IL-1β. These findings would 
suggest that by producing RANTES/CCL5 and IL-8, 
human gingival fibroblasts might participate in the re-
gulation of the local inflammatory process during both 
the acute and the chronic stages of inflammation during 
RAS (53,54).
Considering the anti-inflammatory effects of zinc based 
on the present study, zinc reduces the ROS generation 
and decreases COX-2 expression and PGE2 release in 
PMA-treated hGFs. Based on these result, the inflam-
matory cytokine profile after zinc treatment indicates 
that zinc leads the decrease of the release in secondary 
pro-inflammatory cytokines and chemotactic cytokine 
family for the recruitment of inflammatory cells in the 
periodontal tissue. This evidence suggests that zinc mi-
tigates inflammation and may be clinically useful as an 
anti-inflammatory treatment on RAS.
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